Panagora Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-95,203
| Closed | -$1.92M | – | 1779 |
|
|
2021
Q3 | $1.92M | Buy |
95,203
+57,365
| +152% | +$1.58M | 0.01% | 700 |
|
|
2021
Q2 | $1.41M | Sell |
37,838
-156,328
| -81% | -$4.79M | 0.01% | 843 |
|
|
2021
Q1 | $4.96M | Sell |
194,166
-106,338
| -35% | -$2.72M | 0.03% | 468 |
|
|
2020
Q4 | $6.62M | Buy |
300,504
+228,035
| +315% | +$5.02M | 0.04% | 371 |
|
|
2020
Q3 | $1.3M | Sell |
72,469
-63,842
| -47% | -$1.32M | 0.01% | 809 |
|
|
2020
Q2 | $3.46M | Sell |
136,311
-248,756
| -65% | -$5.36M | 0.02% | 504 |
|
|
2020
Q1 | $7.07M | Buy |
385,067
+382,511
| +14,965% | +$7.43M | 0.05% | 279 |
|
|
2019
Q4 | $56K | Sell |
2,556
-89
| -3% | -$1.79K | ﹤0.01% | 1902 |
|
|
2019
Q3 | $38K | Buy |
+2,645
| New | +$37.8K | ﹤0.01% | 2009 |
|
|
2018
Q3 | – | Sell |
-99,233
| Closed | -$1.22M | – | 2493 |
|
|
2018
Q2 | $1.22M | Buy |
99,233
+91,700
| +1,217% | +$1.15M | ﹤0.01% | 1077 |
|
|
2018
Q1 | $72K | Hold |
7,533
| – | – | ﹤0.01% | 1935 |
|
|
2017
Q4 | $68K | Buy |
7,533
+3,215
| +74% | +$23.7K | ﹤0.01% | 1989 |
|
|
2017
Q3 | $25K | Sell |
4,318
-926
| -18% | -$3.37K | ﹤0.01% | 2155 |
|
|
2017
Q2 | $17K | Hold |
5,244
| – | – | ﹤0.01% | 2315 |
|
|
2017
Q1 | $18K | Buy |
+5,244
| New | +$14.8K | ﹤0.01% | 2198 |
|
|
2016
Q1 | – | Sell |
-6,819
| Closed | -$81K | – | 2363 |
|
|
2015
Q4 | $81K | Sell |
6,819
-2,560
| -27% | -$29.3K | ﹤0.01% | 1854 |
|
|
2015
Q3 | $77K | Buy |
9,379
+5,957
| +174% | +$68.8K | ﹤0.01% | 1882 |
|
|
2015
Q2 | $48K | Buy |
+3,422
| New | +$62.8K | ﹤0.01% | 2157 |
|
Other funds holding DRNA
Panagora Asset Management's DRNA Position: Q4 2021 in Review
Panagora Asset Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 95,203 shares — an estimated $1.92M sold.
Panagora Asset Management first reported a position in DRNA in Q2 2015 and held it in 18 quarters. The position peaked at $7.07M in Q1 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Panagora Asset Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Panagora Asset Management sold 95,203 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1.92M.
- Panagora Asset Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2015 and held it in 18 quarters.
- Panagora Asset Management's Dicerna Pharmaceuticals, Inc. position peaked at $7.07M in Q1 2020.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Panagora Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.